Bondria 150mg Tablet

Introduction

Bondria is a prescription medication that contains the active ingredient Ibandronic Acid. It is available in tablet form and is commonly prescribed under the brand name Bondria. This medication is primarily used in the treatment of osteoporosis in postmenopausal women.

Uses

Bondria is prescribed to treat and prevent osteoporosis in postmenopausal women. Osteoporosis is a condition that causes bones to become weak and brittle, increasing the risk of fractures. This medication helps to improve bone density and reduce the risk of fractures in individuals with osteoporosis.

Dosage and Administration

follow the dosage instructions provided by your healthcare professional. The usual recommended dose of Bondria is 150 mg taken once monthly. The tablet should be taken on an empty stomach, at least 60 minutes before the first food or drink (other than water) of the day. It should be swallowed whole with a full glass of plain water (6 to 8 ounces). Do not chew, crush, or suck on the tablet.

Mechanism of Action

Bondria belongs to a class of medications called bisphosphonates. It works by inhibiting the cells that break down bone, called osteoclasts. By reducing the activity of these cells, Ibandronic Acid helps to slow down bone loss and increase bone density. This mechanism of action helps to strengthen the bones and reduce the risk of fractures in individuals with osteoporosis.

Side Effects

Common side effects may include headache, nausea, diarrhea, and muscle or joint pain. These side effects are usually mild and temporary.

Serious side effects are rare but may include severe bone, joint, or muscle pain, jaw problems (such as jaw pain, numbness, or swelling), and unusual thigh bone fractures. If you experience any of these serious side effects, seek medical attention immediately.

Drug Interactions

inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products. Some medications may interact with Bondria and affect its effectiveness or increase the risk of side effects. Common drug interactions may include nonsteroidal anti-inflammatory drugs (NSAIDs), calcium supplements, and antacids. Discuss all potential drug interactions with your healthcare professional before starting Bondria.

Precautions

Before taking Bondria, inform your healthcare professional about any allergies you may have, as well as any medical conditions you have, such as kidney problems or low blood calcium levels. This medication is not recommended for use in individuals with certain conditions, such as severe kidney impairment or hypocalcemia (low blood calcium levels). Follow all precautions and contraindications provided by your healthcare professional.

Storage

Bondria should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Do not use the medication if the packaging is damaged or if the expiration date has passed. If you have any unused or expired medication, please consult with your pharmacist or healthcare professional for proper disposal methods.

Patient Tips

• Take Bondria on an empty stomach, at least 60 minutes before the first food or drink (other than water) of the day.
• Swallow the tablet whole with a full glass of plain water (6 to 8 ounces). Do not chew, crush, or suck on the tablet.
• maintain an adequate calcium and vitamin D intake while taking this medication. Your healthcare professional may recommend calcium and/or vitamin D supplements if needed.
• If you miss a dose, take it as soon as you remember, unless it is less than 7 days before your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule.
• If you have any questions or concerns about Bondria, speak with your healthcare professional for further guidance and information.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Isovaleric acidaemia (NHS UK) [Accessed 2 Jun. 2024] (online) Available at:
• Bondronat 2 mg Concentrate for Solution for Infusion (Health Professionals SmPC) Available at:
• Ibandronic Acid (International database) (Drugs.com) [Accessed 22 Jun. 2024] (online) Available at:
• Wang WY, Chen LH, Ma WJ, You RX. Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials. Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):8253-8268. doi: 10.26355/eurrev_202309_33586. [Accessed 25 Jun. 2024] Available at: